Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Fungal Phylum Microsporidia

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...

Antifungal Agents

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Trends, center level practice, and outcomes of heart transplantation in people with HIV.

JHLT open·2026

Same author

Epidemiology and Clinical Features of Cryptococcosis Among Individuals Without HIV Infection: An Observational International Multicenter Study (MSG-11).

Open forum infectious diseases·2026

Same author

Chagas Cardiomyopathy in the United States: Testing and Diagnosis Across Real-World Datasets.

The American journal of cardiology·2026

Same author

Exploring Early Antifungal Activity of Rezafungin as a Stepping-Stone for Shorter Treatment Duration for Candidemia: Pooled Analysis of 2 Randomized Trials.

Open forum infectious diseases·2026

Same author

It Takes Two to Transplant.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Same author

Kaposi Sarcoma-Associated Herpesvirus Infection and Complications Among Solid Organ Transplant Recipients - United States, January 2021-September 2025.

MMWR. Morbidity and mortality weekly report·2026

Search research articles

Related Experiment Video

Updated: May 12, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

Cryptococcal infections: changing epidemiology and implications for therapy.

Ricardo M La Hoz¹, Peter G Pappas

¹Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, 1900 University Blvd, THT 229, Birmingham, AL 35294-0006, USA.

|April 12, 2013

Summary

This summary is machine-generated.

HIV-associated cryptococcosis remains a major threat in sub-Saharan Africa, despite advances like the lateral flow assay cryptococcal antigen (LFA CrAg) for early diagnosis and pre-emptive fluconazole treatment. New insights into Cryptococcus gattii and C. neoformans aid in understanding and managing these fungal infections.

More Related Videos

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

Related Experiment Videos

Last Updated: May 12, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

Area of Science:

Mycology
Infectious Diseases
Immunology

Background:

HIV-associated cryptococcosis causes significant mortality in sub-Saharan Africa.
Cryptococcosis is a common invasive fungal infection in solid organ transplant recipients.
Emergence of Cryptococcus gattii in new geographic regions presents challenges.

Purpose of the Study:

To review recent advances in diagnosing and treating cryptococcosis, particularly in resource-limited settings.
To highlight new understanding of Cryptococcus gattii and C. neoformans infections.
To inform future treatment strategies for cryptococcosis.

Main Methods:

Review of recent literature on cryptococcosis diagnosis and treatment.
Analysis of the impact of lateral flow assay cryptococcal antigen (LFA CrAg).
Discussion of emerging Cryptococcus species and outbreaks.

Main Results:

LFA CrAg enables pre-emptive treatment with fluconazole for at-risk HIV-positive patients.
Cryptococcosis is the third most common invasive fungal infection in solid organ transplant recipients.
Cryptococcus gattii outbreaks provide insights into pathogen emergence.

Conclusions:

Advances in diagnostics and pre-emptive treatment are improving outcomes for HIV-associated cryptococcosis.
Further research into Cryptococcus species and host factors is crucial for effective management.
Personalized treatment strategies considering infection site, severity, species, and host immunity are needed.